Article
Reconstructing the Origin and Demographic Expansion of the TP53 p.R337H Founder Variant in Brazil.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 3 Feb 2026
Pinto Emilia Modolo, Muzzi João Carlos Degraf, Yunes José Andres, de Figueiredo Bonald Cavalcante, Ribeiro Raul C, Zambetti Gerard P
Abstract excerpt
BACKGROUND: The TP53 p.R337H variant is a well-characterized founder mutation with an unusually high prevalence in Brazil, particularly in the South and Southeast regions, where it affects approximately one in 300 individuals. It is recurrently associated with pediatric adrenocortical tumors and malignancies within the Li-Fraumeni syndrome spectrum but exhibits markedly incomplete penetrance, suggesting the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
